Home / Mumbai / Mumbai News / Article /
Mumbai: 111 mucormycosis patients undergoing treatment in city, says BMC
Updated On: 12 May, 2021 08:30 PM IST | Mumbai | PTI
The BMC's Central Purchase Authority is procuring antifungal drug Amphotericin B which is used to treat mucormycosis and hospitals have been authorised to purchase it locally.
Listen to this article :

This picture has been used for representational purpose
As many as 111 patients, all Covid-19 survivors, are undergoing treatment for the fungal infection "mucormycosis'' in Mumbai hospitals, the Brihanmumbai Municipal Corporation (BMC) informed on Wednesday.
Prabhakar Shinde, the BJP's group leader in the BMC said the information was provided to the civic body's standing committee upon his query.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

